MEDS

Question 1

antidepressants ADRs

Answer 1

setraline, fluoxetine

ADDE, reduced accommodation, light sensitivity

Question 2

beta blockers ADRs

Answer 2

atenolol, propranolol, timolol (POAG)

for HBP, anxiety, angina, migraines

ADDE

Question 3

post-menopausal ADR

Answer 3

HRT

ADDE

Question 4

anti-coagulants ADRs

Answer 4

warfarin, aspirin, apixaban

blood thinners - prevent stroke/ heart attack

sub-conjunctival haemorrhage, vitreous/ retinal haemorrhage

Question 5

anti-rheumatic/ malarial ADRs

Answer 5

hydroxychloroquine

for rheumatoid arthritis

blurred vision, bulls eye maculopathy

Question 6

steroids ADRs

Answer 6

prednisolone, dexamethasone

long term >10mg daily = chronic dose = higher risk

to reduce inflammation

increased IOPs, cataract, exophthalmos

Question 7

prostaglandin analogues (topical) ADRs

Answer 7

bimatoprost (Lumigan), latanoprost (Xalatan)

for POAG

ocular irritation, hyperaemia, iris hyperpigmentation, increase in lash length/ thickness/ pigmentation, increase in lid skin pigmentation

Question 8

reporting scheme on ADR (MHRA)

Answer 8

yellow card scheme - covers systemic ADRs to ocular medicines and ocular reactions to systemic meds

the medical devices reporting form - covers adverse incidents mainly relating to CLs + care products

Question 9

BNF symbol T

Answer 9

suspected reactions to new meds

Question 10

BNF inverted black triangle

Answer 10

new medicines and vaccines under additional monitoring have this symbol on package leaflet